Biosenta Inc.
ZRO
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.50% | 64.81% | 65.11% | -1,449.37% | -1,060.69% |
| Total Depreciation and Amortization | 58.33% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.28% | -72.59% | -76.76% | 420.58% | 396.25% |
| Change in Net Operating Assets | -14.95% | -59.21% | -65.48% | -24.82% | -5.74% |
| Cash from Operations | 36.16% | 15.79% | -40.29% | -52.58% | -40.95% |
| Capital Expenditure | -59.48% | -59.48% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -59.48% | -59.48% | -- | -- | -- |
| Total Debt Issued | -27.66% | -34.08% | -99.96% | -77.15% | -22.47% |
| Total Debt Repaid | -- | -- | -- | -60,100.00% | -- |
| Issuance of Common Stock | 20.00% | 128.65% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2,650.35% | 28.31% | -- | -- | -- |
| Cash from Financing | -36.00% | -38.18% | 42.12% | 61.41% | 79.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -257.45% | -182.14% | 106.96% | 33.59% | 105.68% |